Across TCGA pan-cancer cohorts, SCAPER Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SCAPER data layer compared with 26 for mass-spec protein and 4 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SCAPER Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated SCAPER expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
UCEC, READ, and LUSC are the cancer types where SCAPER Mutation most reproducibly stratifies survival.